Sponsored by:

Molecular Imaging: Page 509

PET/CT improves diagnostic accuracy of unexpected malignancies
By N. Shivapriya
The use of PET/CT can decrease uncertainty and improve diagnostic accuracy in 18-F FDG-PET studies to detect unexpected malignancies, according to two recent studies in the Journal of Nuclear Medicine.
June 29, 2005
Radiopharmaceuticals market to reach $3.2 billion by 2010
By AuntMinnie.com staff writers
The overall U.S. market for diagnostic radiopharmaceuticals reached $1.53 billion in 2004 and is expected to rise to $3.2 billion by 2010, according to a recent study by market research firm Bio-Tech Systems.
June 28, 2005
IsoRay raises $10 million
By AuntMinnie.com staff writers
Medical isotope developer IsoRay has closed its final round of angel and private capital fundraising, according to the Richland, WA-based firm.
June 27, 2005
MDS Nordion targets drug discovery
By AuntMinnie.com staff writers
Canadian radioisotope developer MDS Nordion of Kanata, Ontario, is expanding the range of services it offers to include drug discovery and development.
June 27, 2005
Gamma Medica licenses pinhole technology
By AuntMinnie.com staff writers
Molecular imaging system developer Gamma Medica of Northridge, CA, has licensed pinhole image reconstruction technology from Johns Hopkins University in Baltimore.
June 22, 2005
Multiple modalities show similar results for initial staging of head and neck cancer
By Jonathan S. Batchelor
TORONTO - Head and neck cancer is the fifth most common cancer worldwide and accounts for 2.8% of all malignancies in the U.S., according to presentations this week at the Society of Nuclear Medicine (SNM) conference. Multimodality management of head and neck cancer patients is now the modus operandi in most medical centers.
June 22, 2005
Cedara inks molecular software deal
By AuntMinnie.com staff writers
Merge Healthcare's Cedara Software division has signed an agreement with Molecular Therapeutics of Ann Arbor, MI, to market and sell software for functional diffusion mapping.
June 21, 2005
PET mammography unit shows promise for DCIS
By Brian Casey
TORONTO - A dedicated PET mammography unit turned in good results in detecting ductal carcinoma in situ (DCIS) in symptomatic high-risk patients, according to research presented this week at the Society of Nuclear Medicine (SNM) meeting. The research indicates that the PEM scanner could help breast imagers detect cancer at an earlier stage, before it has metastasized.
June 21, 2005
2005 06 21 15 03 29 706
Coronary PET links obesity to endothelial dysfunction, increased FDG uptake
By Jonathan S. Batchelor
TORONTO - Obesity is associated with abnormal coronary circulatory function and increases FDG uptake in large arteries, according to a pair of presentations at the Society of Nuclear Medicine (SNM) meeting this week.
June 21, 2005
SNM taps Conti as president
Dr. Peter Conti, Ph.D, will serve as president of the Society of Nuclear Medicine (SNM) until June 2006.
June 20, 2005
Cytogen cites promising results for cancer pain medication
By AuntMinnie.com staff writers
Biopharmaceutical firm Cytogen announced the results of a study that evaluated the use of its nonopioid therapeutic pain medication alone and in conjunction with chemotherapy for the treatment of prostate, breast, lung, and other cancers.
June 20, 2005
Gamma Medica merges with Ideas
By AuntMinnie.com staff writers
Imaging system developer Gamma Medica of Northridge, CA, is combining operations with Ideas ASA of Oslo, Norway, a producer of imaging detector subsystems. The resulting company will be called Gamma Medica Ideas.
June 20, 2005
Previous Page
Page 509 of 615
Next Page